HomeBTAI • NASDAQ
add
BioXcel Therapeutics Inc
Previous close
$1.82
Day range
$1.76 - $1.87
Year range
$1.29 - $48.72
Market cap
9.90M USD
Avg Volume
856.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 366.00K | -2.66% |
Operating expense | 10.00M | -48.84% |
Net income | -10.86M | 51.21% |
Net profit margin | -2.97K | 49.88% |
Earnings per share | -3.56 | 70.70% |
EBITDA | -10.38M | 47.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.85M | -54.23% |
Total assets | 38.34M | -47.98% |
Total liabilities | 131.44M | 0.94% |
Total equity | -93.10M | — |
Shares outstanding | 5.49M | — |
Price to book | -0.06 | — |
Return on assets | -59.96% | — |
Return on capital | -179.24% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.86M | 51.21% |
Cash from operations | -14.81M | 44.87% |
Cash from investing | — | — |
Cash from financing | 4.28M | 101.41% |
Net change in cash | -10.53M | 57.43% |
Free cash flow | -12.42M | 39.49% |
About
Founded
2017
Headquarters
Website
Employees
37
